Eaton Vance Management Sells 1,297 Shares of CME Group Inc (CME)

Eaton Vance Management lessened its stake in shares of CME Group Inc (NASDAQ:CME) by 0.4% in the third quarter, HoldingsChannel reports. The firm owned 316,360 shares of the financial services provider’s stock after selling 1,297 shares during the quarter. Eaton Vance Management’s holdings in CME Group were worth $53,848,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. BP PLC boosted its stake in CME Group by 2.2% in the 3rd quarter. BP PLC now owns 102,200 shares of the financial services provider’s stock worth $17,396,000 after buying an additional 2,200 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its stake in CME Group by 3.2% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 1,207,970 shares of the financial services provider’s stock worth $198,011,000 after buying an additional 37,225 shares during the last quarter. Sun Life Financial INC boosted its stake in CME Group by 267.7% in the 2nd quarter. Sun Life Financial INC now owns 923 shares of the financial services provider’s stock worth $151,000 after buying an additional 672 shares during the last quarter. Oak Ridge Investments LLC lifted its stake in shares of CME Group by 6.2% in the 2nd quarter. Oak Ridge Investments LLC now owns 5,247 shares of the financial services provider’s stock valued at $860,000 after purchasing an additional 306 shares in the last quarter. Finally, Nisa Investment Advisors LLC lifted its stake in shares of CME Group by 13.4% in the 3rd quarter. Nisa Investment Advisors LLC now owns 122,863 shares of the financial services provider’s stock valued at $20,912,000 after purchasing an additional 14,534 shares in the last quarter. Hedge funds and other institutional investors own 84.55% of the company’s stock.

Several research firms have recently weighed in on CME. Atlantic Securities began coverage on CME Group in a research note on Wednesday. They issued a “neutral” rating and a $200.00 price objective on the stock. UBS Group lowered CME Group from a “buy” rating to a “neutral” rating and lifted their price objective for the company from $185.00 to $204.00 in a research note on Wednesday. Citigroup began coverage on CME Group in a research note on Tuesday, November 20th. They issued a “buy” rating and a $220.00 price objective on the stock. Berenberg Bank raised CME Group from a “hold” rating to a “buy” rating and set a $220.00 price objective on the stock in a research note on Tuesday, November 20th. Finally, Deutsche Bank lifted their price objective on CME Group from $205.00 to $206.00 and gave the company a “buy” rating in a research note on Friday, November 16th. Six analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $191.80.

NASDAQ CME opened at $190.08 on Friday. The stock has a market capitalization of $64.60 billion, a PE ratio of 39.85, a PEG ratio of 2.21 and a beta of 0.49. CME Group Inc has a 1-year low of $143.68 and a 1-year high of $197.08. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, October 25th. The financial services provider reported $1.45 EPS for the quarter, topping the consensus estimate of $1.42 by $0.03. The firm had revenue of $904.20 million for the quarter, compared to analyst estimates of $910.50 million. CME Group had a return on equity of 9.18% and a net margin of 113.67%. Sell-side analysts expect that CME Group Inc will post 6.65 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 27th. Investors of record on Monday, December 10th will be given a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 1.47%. The ex-dividend date is Friday, December 7th. CME Group’s dividend payout ratio (DPR) is presently 58.70%.

In related news, Chairman Terrence A. Duffy sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, November 23rd. The stock was sold at an average price of $188.80, for a total transaction of $1,888,000.00. Following the transaction, the chairman now directly owns 95,652 shares of the company’s stock, valued at approximately $18,059,097.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $172.30, for a total value of $51,690.00. Following the transaction, the director now directly owns 42,912 shares in the company, valued at $7,393,737.60. The disclosure for this sale can be found here. Insiders have sold a total of 44,419 shares of company stock worth $8,193,732 over the last three months. 0.43% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “Eaton Vance Management Sells 1,297 Shares of CME Group Inc (CME)” was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://www.com-unik.info/2018/12/02/eaton-vance-management-sells-1297-shares-of-cme-group-inc-cme.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

See Also: New Google Finance Tool and Screening Stocks

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit